Slavin S - Search Results

1

Modulation of experimental systemic lupus erythematosus with linomide.

Zandman-Goddard G, George J, Levy Y, Blank M, Slavin S, Shoenfeld Y. Zandman-Goddard G, et al. Among authors: slavin s. Lupus. 1996 Aug;5(4):328-33. doi: 10.1177/096120339600500415. Lupus. 1996. PMID: 8869907

2

Induction of tolerance to experimental anti-phospholipid syndrome (APS) by syngeneic bone marrow cell transplantation.

Blank M, Tomer Y, Slavin S, Shoenfeld Y. Blank M, et al. Among authors: slavin s. Scand J Immunol. 1995 Aug;42(2):226-34. doi: 10.1111/j.1365-3083.1995.tb03649.x. Scand J Immunol. 1995. PMID: 7631156

3

Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide.

Karussis DM, Lehmann D, Slavin S, Vourka-Karussis U, Mizrachi-Koll R, Ovadia H, Ben-Nun A, Kalland T, Abramsky O. Karussis DM, et al. Among authors: slavin s. Ann Neurol. 1993 Nov;34(5):654-60. doi: 10.1002/ana.410340506. Ann Neurol. 1993. PMID: 8239559

4

Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).

Karussis DM, Lehmann D, Slavin S, Vourka-Karussis U, Mizrachi-Koll R, Ovadia H, Kalland T, Abramsky O. Karussis DM, et al. Among authors: slavin s. Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6400-4. doi: 10.1073/pnas.90.14.6400. Proc Natl Acad Sci U S A. 1993. PMID: 8341645 Free PMC article.

5

Prevention of autoimmune diabetes by linomide in nonobese diabetic (NOD) mice is associated with up-regulation of the TCR-mediated activation of p21(ras).

Rapoport MJ, Weiss L, Mor A, Bistritzer T, Ramot Y, Slavin S. Rapoport MJ, et al. Among authors: slavin s. J Immunol. 1996 Nov 15;157(10):4721-5. J Immunol. 1996. PMID: 8906854

6

The immunomodulator Linomide: role in treatment and prevention of autoimmune diabetes mellitus.

Gross DJ, Weiss L, Reibstein I, Hedlund G, Dahlén E, Rapoport MJ, Slavin S. Gross DJ, et al. Among authors: slavin s. Int Immunopharmacol. 2001 Jun;1(6):1131-9. doi: 10.1016/s1567-5769(01)00042-x. Int Immunopharmacol. 2001. PMID: 11407307 Review.

7

Immunomodulation of autoimmunity by linomide.

Karussis DM, Lehmann D, Slavin S, Kalland T, Vourka-Karussis U, Mizrachi-Koll R, Ovadia H, Abramsky O. Karussis DM, et al. Among authors: slavin s. Isr J Med Sci. 1995 Jan;31(1):38-41. Isr J Med Sci. 1995. PMID: 7836046 No abstract available.

8

The effect of linomide, an immunoregulator in experimental autoimmune diseases, on humoral antibody responses in mice.

Morecki S, Nabet C, Falk P, Fridkis-Hareli M, Pecht I, Mond JJ, Slavin S. Morecki S, et al. Among authors: slavin s. Autoimmunity. 1997;25(4):223-32. doi: 10.3109/08916939708994731. Autoimmunity. 1997. PMID: 9344330 Free article.

9

Successful treatment of diabetes in NOD mice with advanced disease by islet isografts following immunoregulation with Linomide (quinoline-3-carboxamide).

Slavin S, Weiss L, Xia W, Gross DJ. Slavin S, et al. Cell Transplant. 1996 Nov-Dec;5(6):627-30. doi: 10.1177/096368979600500605. Cell Transplant. 1996. PMID: 8951220

10

Prevention of diabetes mellitus in non-obese diabetic mice by Linomide, a novel immunomodulating drug.

Gross DJ, Sidi H, Weiss L, Kalland T, Rosenmann E, Slavin S. Gross DJ, et al. Among authors: slavin s. Diabetologia. 1994 Dec;37(12):1195-201. doi: 10.1007/BF00399792. Diabetologia. 1994. PMID: 7895948

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

768 results

Search Page

Filters